HIV prevention drug, billions in corporate profits after millions in taxpayer investments : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, May 16, 2019
Type
Label
HIV prevention drug, billions in corporate profits after millions in taxpayer investments : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, May 16, 2019
Language
eng
resource.governmentPublication
federal national government publication
Index
no index present
Literary Form
non fiction
Main title
HIV prevention drug
Medium
electronic resource
Nature of contents
dictionaries
Oclc number
1112074275
Sub title
billions in corporate profits after millions in taxpayer investments : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, May 16, 2019
resource.variantTitle
Human Immunodeficiency Virus prevention drugBillions in corporate profits after millions in taxpayer investments
Genre
Subject
- Emtricitabine/tenofovir disoproxil fumarate -- United States
- Medical policy -- United States
- Gilead Sciences (Firm)
- Pharmaceutical industry + Prices + Government policy -- United States
- HIV infections -- United States -- Prevention
- Federal aid to medical research -- United States
- Legislative hearings
- Pre-exposure prophylaxis -- United States -- Cost control
- Pre-exposure prophylaxis + Prices -- United States
- Prescription pricing + Government policy -- United States
Content
Mapped to
Incoming Resources
- Has instance1
Outgoing Resources
- Creator1
- Genre1
- Subject10
- Emtricitabine/tenofovir disoproxil fumarate -- United States
- Medical policy -- United States
- Gilead Sciences (Firm)
- Pharmaceutical industry + Prices + Government policy -- United States
- HIV infections -- United States -- Prevention
- Federal aid to medical research -- United States
- Legislative hearings
- Pre-exposure prophylaxis -- United States -- Cost control
- Pre-exposure prophylaxis + Prices -- United States
- Prescription pricing + Government policy -- United States
- Content1
- Author1
- Other version1
- Mapped to1